HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased levels of sigJ mRNA in late stationary phase cultures of Mycobacterium tuberculosis detected by DNA array hybridisation.

Abstract
In order to determine which genes are involved in maintaining viability of 100-day stationary-phase bacteria and persistent bacteria after antibiotic treatment, we used a mini-DNA array to examine the transcription of 82 genes of M. tuberculosis in the 100-day stationary-phase cultures before and after rifampicin treatment. We found that the mRNA level of a sigma factor gene, sigJ, was strongly up-regulated in the late stationary-phase cultures. Other genes were also up-regulated, although to a lesser extent than sigJ. Surprisingly, after rifampicin treatment there was no significant change in sigJ expression, and most of the other 82 genes in the mini-DNA array also maintained expression, some at relatively high levels. These results suggest that SigJ may control gene expression in the quiescent state and may be an important component in the mechanisms by which M. tuberculosis survives prolonged stationary phase even in the presence of sterilising antibiotics.
AuthorsY Hu, A R Coates
JournalFEMS microbiology letters (FEMS Microbiol Lett) Vol. 202 Issue 1 Pg. 59-65 (Aug 07 2001) ISSN: 0378-1097 [Print] England
PMID11506908 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • RNA, Bacterial
  • Rifampin
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Cell Division (drug effects)
  • Gene Expression Profiling
  • Gene Expression Regulation, Bacterial (drug effects)
  • Genes, Bacterial (genetics)
  • Mycobacterium tuberculosis (cytology, genetics, growth & development)
  • Oligonucleotide Array Sequence Analysis
  • RNA, Bacterial (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rifampin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: